Specifically, APRIL preferably binds to BCMA with much higher affinity than BAFF [83,99] and is predominantly produced by myeloid cells, macrophages, OC precursor cells, and OCs which play central pathophysiological roles in MM-induced bone lesions. Here, TNFSF13B is linked to Miyoshi myopathy.